Iron management in end-stage renal disease
- 31 March 1997
- journal article
- review article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 29 (3), 319-333
- https://doi.org/10.1016/s0272-6386(97)90192-x
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Effect of Serum Parathyroid Hormone and Bone Marrow Fibrosis on the Response to Erythropoietin in UremiaNew England Journal of Medicine, 1993
- A comparison of the responses to recombinant human erythropoietin in normal and uremic subjectsKidney International, 1992
- Inhibition of iron absorption by omeprazole in rat modelDigestive Diseases and Sciences, 1991
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989
- Epidemiology in Nursing and Health CareThe American Journal of Nursing, 1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Ferritinaemia in cancerNature, 1977
- Valency Investigations of Iron Dextran (‘Imferon’)Nature, 1965
- The diagnosis of iron deficiency anemiaAmerican Journal Of Medicine, 1964
- The Intravenous Glucose Tolerance Test in Atherosclerotic Disease with Special Reference to Obesity, Hypertension, Diabetic Heredity and Cholesterol ValuesActa Medica Scandinavica, 1962